Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kennel

Showing results (581-590 of 589) with videos related to

Pageof 59
Sort By:
You have reached the last page of results.This site can display upto 589 results.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
European Radiology|November 6, 2020
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PMLManel Alleg, Morgane Solis, Seyyid Baloglu, et al.
Autoimmunity Reviews|July 8, 2021
IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypesAurore Moussiegt, Romain Müller, Mikaël Ebbo, et al.
Journal of Proteome Research|July 2, 2008
A general system for studying protein-protein interactions in Gram-negative bacteriaDale A Pelletier, Gregory B Hurst, Linda J Foote, et al.
Cancer Discovery|July 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy ResponsesHenner F Farin, Mohammed H Mosa, Benardina Ndreshkjana, et al.
Nature Medicine|March 15, 2022
The MHC class I MICA gene is a histocompatibility antigen in kidney transplantationRaphael Carapito, Ismail Aouadi, Martin Verniquet, et al.
Blood|September 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencingAnaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, et al.
American Journal of Hematology|May 5, 2018
HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantationStéphanie Ducreux, Valérie Dubois, Kahina Amokrane, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Pageof 59

Showing results (581-590 of 589) with videos related to

Sort By:
Pageof 59
You have reached the last page of results.This site can display upto 589 results.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
European Radiology|November 6, 2020
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PMLManel Alleg, Morgane Solis, Seyyid Baloglu, et al.
Autoimmunity Reviews|July 8, 2021
IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypesAurore Moussiegt, Romain Müller, Mikaël Ebbo, et al.
Journal of Proteome Research|July 2, 2008
A general system for studying protein-protein interactions in Gram-negative bacteriaDale A Pelletier, Gregory B Hurst, Linda J Foote, et al.
Cancer Discovery|July 25, 2023
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy ResponsesHenner F Farin, Mohammed H Mosa, Benardina Ndreshkjana, et al.
Nature Medicine|March 15, 2022
The MHC class I MICA gene is a histocompatibility antigen in kidney transplantationRaphael Carapito, Ismail Aouadi, Martin Verniquet, et al.
Blood|September 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencingAnaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, et al.
American Journal of Hematology|May 5, 2018
HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantationStéphanie Ducreux, Valérie Dubois, Kahina Amokrane, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Pageof 59